Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Journal of the National Cancer Institute|April 5, 2001
Gender- and smoking-related bladder cancer riskJ E Castelao, J M Yuan, P L Skipper, et al.
Genetic Epidemiology|January 1, 1987
Genetic etiology of gastric carcinoma: II. Segregation analysis of gastric pH, nitrate, and nitriteG E Bonney, R C Elston, P Correa, et al.
Cancer Research|October 1, 1991
Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controlsA Weston, N E Caporaso, K Taghizadeh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 27, 2000
N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levelsN M Probst-Hensch, D A Bell, M A Watson, et al.
Princess Takamatsu Symposia|January 1, 1995
MeIQx (2-amino-3,8-dimethylimidazo [4,5-f]quinoxaline): metabolism in humans and urinary metabolites in human populationsS R Tannenbaum, W G Stillwell, H Ji, et al.
Current Drug Metabolism|December 29, 2005
A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme inductionA Sivaraman, J K Leach, S Townsend, et al.
Chemical Research in Toxicology|November 1, 1992
Fluoranthene metabolism: human and rat liver microsomes display different stereoselective formation of the trans-2,3-dihydrodiolB W Day, Y Sahali, D A Hutchins, et al.
Cancer Research|August 15, 1991
Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenylF F Kadlubar, K L Dooley, C H Teitel, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2015
Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS IntegrationJ Yu, N A Cilfone, E M Large, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 26, 2000
Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseasesS P Hussain, K Raja, P A Amstad, et al.
Pageof 29